
Addressing your patient's sexual function after cancer
Oct 4, 2018 - 08:26
Radio and PodcastLive Radio & Podcasts
Dr. Richard-Davis served as the Scientific Program Chair of the 2018 North American Menopause Society (NAMS) Meeting. In this audiocast she highlights several clinical takeaways from the meeting, including: new treatment...
New and promising GSM treatments, more clinical takeaways from NAMS 2018 is an episode from OBGcast by Tyler Mundhenk. Dr. Richard-Davis served as the Scientific Program Chair of the 2018 North American Menopause Society (NAMS) Meeting. In...
This episode belongs to OBGcast.
Use the player on this page to stream the episode online.
Published Oct 17, 2018, 22:19 long, audio available.
Dr. Richard-Davis served as the Scientific Program Chair of the 2018 North American Menopause Society (NAMS) Meeting. In this audiocast she highlights several clinical takeaways from the meeting, including: new treatments for uterine fibroids the telomere's role in helping women live longer lives, and protective (estrogen) and adverse (stress, obesity) factors affecting telomere length that patients can address through a healthy lifestyle the legal risks of not screening for hereditary cancer obesity prevention, treatment, and long-term lifestyle changes during menopause new and on-the-horizon therapies for GSM much more.
You can listen to New and promising GSM treatments, more clinical takeaways from NAMS 2018 online on Radio and Podcast. Open the player on this page to stream the available audio.
New and promising GSM treatments, more clinical takeaways from NAMS 2018 is an episode from OBGcast by Tyler Mundhenk.
This episode is 22:19 long.
This episode was published on Oct 17, 2018.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from OBGcast when more episodes are available from the podcast feed.
You can listen to New and promising GSM treatments, more clinical takeaways from NAMS 2018 on this page when the episode audio is available from the podcast feed.
New and promising GSM treatments, more clinical takeaways from NAMS 2018 is from OBGcast by Tyler Mundhenk.
Published Oct 17, 2018 and 22:19 long